Roivant Sciences Reports Financial Results for the Third Quarter Ended December 31, 2022 and Provides Business Update

Go back to Roivant Sciences Reports Financial Results for the Third Quarter Ended December 31, 2022 and Provides Business Update

Roivant Sciences Ltd. (ROIV) Misses Q3 EPS by 5c, Revenues Beat

February 13, 2023 7:17 AM EST

Roivant Sciences Ltd. (NASDAQ: ROIV) reported Q3 non-GAAP EPS of ($0.42), $0.05 worse than the analyst estimate of ($0.37). Revenue for the quarter came in at $17.05 million versus the consensus estimate of $14.11 million.

For earnings history and earnings-related data on Roivant Sciences Ltd. (ROIV) click here.

... More